Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

REVOLUTION Medicines patents SOS1 inhibitors

Sep. 22, 2020

New phase I trial evaluates Apomab theranostic for lung and ovarian cancer

Sep. 22, 2020

Optikira synthesizes new ERN1 inhibitors

Sep. 21, 2020

Chinese researchers disclose ENPP2 inhibitors

Sep. 21, 2020

Merck KGaA divulges PTPN11 inhibitors

Sep. 21, 2020

Tissue-specific p53 effects could aid drug development

Sep. 21, 2020

Inhibition of alpha-KG-producing enzymes is therapeutic in diffuse intrinsic pontine glioma models

Sep. 21, 2020

Papyrus and Oxford Biomedica sign research collaboration agreement for CAR-T cell development

Sep. 18, 2020

INT-230-6 studied in combination with Yervoy for advanced cancers in phase II

Sep. 18, 2020

Junshi and Wigen collaborate on four of Wigen's cancer drug candidates

Sep. 18, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...